Neurotez Revenue and Competitors
Estimated Revenue & Valuation
- Neurotez's estimated annual revenue is currently $930k per year.
- Neurotez's estimated revenue per employee is $155,000
Employee Data
- Neurotez has 6 Employees.
- Neurotez grew their employee count by 0% last year.
Neurotez's People
Name | Title | Email/Phone |
---|---|---|
1 | President & CEO | Reveal Email/Phone |
Neurotez Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.5M | 55 | -21% | N/A | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $8.5M | 55 | -29% | N/A | N/A |
#4 | $108.5M | 500 | 2% | N/A | N/A |
#5 | $0.8M | 5 | 0% | N/A | N/A |
#6 | $0.6M | 4 | 0% | N/A | N/A |
#7 | $14.7M | 68 | -23% | $206.4M | N/A |
#8 | $492.2M | 1503 | -15% | $568M | N/A |
#9 | $1.1M | 7 | -42% | N/A | N/A |
#10 | $4.5M | 29 | 0% | N/A | N/A |
What Is Neurotez?
Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim.
keywords:N/AN/A
Total Funding
6
Number of Employees
$930k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.1M | 7 | -75% | N/A |
#2 | $0.5M | 7 | 0% | N/A |
#3 | $0.8M | 8 | -58% | N/A |
#4 | $0.6M | 8 | -20% | N/A |
#5 | $0.9M | 10 | -33% | N/A |